DIGITAL-VAULT-SERVICES
17.4.2024 09:01:28 CEST | Business Wire | Press release
Clearstream, Deutsche Börse’s post-trade business, intends to make an investment in Digital Vault Services (DVS), a pioneering fintech offering issuance and safekeeping services for digital bank guarantees and sureties in Europe. The investment is subject to applicable regulatory approvals and finalisation of legal documentation.
The investment enables DVS to further enhance and broaden its offering as a market infrastructure solution for corporates and financial institutions. The mid-term plan will be to integrate DVS’s Guarantee Vault with D7, the digital post-trade platform of Deutsche Börse and its post-trade business Clearstream. This will allow D7 for the first time to expand its digital asset product portfolio to non-securities.
With DVS’s established offering in Europe coupled with Clearstream’s leverage and experience offering market infrastructure solutions and connectivity, both parties seek to bring added value to the trade finance ecosystem of corporates, banks and insurers.
Jens Hachmeister, Head of Issuer Services & New Digital Markets at Clearstream, said: “Digital leadership is a central part of Deutsche Börse Group’s Horizon 2026 strategy. The companies’ shared commitment to market innovation makes DVS a perfect fit for Deutsche Börse and Clearstream. We are convinced that DVS’s innovative approach to digital bank guarantees, combined with D7’s track record in digitising securities and Clearstream’s central role in global financial markets, will drive significant growth and deliver value for our clients and ultimately the entire financial industry.”
Ludger Janssen, Co-CEO of Digital Vault Services, added: “Clearstream has emerged as a strategic ally for DVS, echoing our dedication to streamlining processes and recognizing the transformative potential of digitisation in the financial industry, in particular with regards to guarantee management. With technology as our foundation, together with Clearstream and our central and digital guarantee registry, we foresee a unique end-to-end solution that disrupts and modernises outdated procedures with unparalleled efficiency.”
Jaime Gimeno, Co-CEO of Digital Vault Services, added: “Back in 2018, when designing a solution to the cumbersome paper-based process for issuing and storing guarantees, we took inspiration from the central securities depository model used in the securities industry. This strategic partnership with Clearstream now represents a major milestone in our growth journey towards becoming the recognized market infrastructure solution for guarantees in Europe. As we move forward the partnership also positions DVS for exciting new use cases and instruments.”
The investment will be done in exchange for a minority stake and is expected to be completed in H2/2024, subject to applicable regulatory approvals and finalisation of legal documentation.
Digitising financial markets
Today’s financial markets are highly fragmented with isolated technology solutions, resulting in slow processes, high error rates and costs for all market participants. Digital solutions aim to counter these problems by connecting networks and market players across system boundaries, thereby boosting transparency, process efficiency and technology interoperability.
Deutsche Börse and its post-trade business Clearstream provide with their digital post-trade platform D7 a fully digital alternative to conventional physical issuance and managing of financial securities, reducing the time-to-market for securities from days to minutes.
With its Guarantee Vaults product, DVS provides a digital solution allowing corporates to centrally issue and store bank guarantees that are required across different segments as industry standard.
[Editorial note: Please find here a high-resolution photo of Jens Hachmeister.]
About Clearstream
Clearstream is the innovative and trusted post-trade business for the global markets. It runs the leading securities and funds servicing ecosystems of tomorrow. The company operates the German and Luxembourg central securities depositories and an international central securities depository for the Eurobonds market. With 18 trillion Euros in assets under custody, it is one of the world’s largest settlement and custody firms for domestic and international securities.
It also delivers premier fund execution, distribution, data and reporting services, covering over 55 fund markets worldwide. Clearstream is part of Deutsche Börse Group, an international exchange organisation and provider of innovative market infrastructures.
To learn more, visit us at www.clearstream.com or connect via LinkedIn.
About Digital Vault Services
The idea for Digital Vault Services emerged in 2017 from the needs of the Treasury department of Lindner Group KG, Arnstorf, Germany. A strong working group of corporates and financial institutions from across Europe then came together to design a market solution to a common problem around the paper-based guarantee process. Since then, Digital Vault Services has rapidly evolved, gaining strong traction in DACH and now expanding into other European markets including the Nordics. Headquartered in Munich, Germany, Digital Vault Services is at the forefront of guarantee digitisation. The current shareholders, being Lindner Group KG and Management, now welcome Deutsche Börse to join them on the exciting journey ahead.
Visit us at www.digitalvaultservices.com or connect via LinkedIn to get to know more about Digital Vault Services and Guarantee Vault.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240417214758/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom